Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Pristine Surgical

Explore full profile

Single-use 4K surgical scopes with cloud software

Manchester, United StatesFounded 2013Health Tech & Medtech
Valuation $100–250M Last recorded · 2020
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Pristine Surgical and the history behind them.

About Pristine Surgical

Pristine Surgical is a medical device company, founded in 2011, dedicated to simplifying endoscopy. The company provides a single-use visualization platform for surgical procedures, addressing challenges associated with reusable endoscopes, such as high maintenance costs, wear and tear, and potential for cross-contamination.

The company was co-founded by Bryan Lord, who serves as CEO. His background as a technology lawyer and in venture creation led him to connect two sports medicine surgeons with medical technology developer Dean Kamen, which formed the origins of Pristine Surgical. The company's initial concept, developed by the surgeons, was a pan-able scope that could offer multiple viewing angles in one device. However, the strategic focus shifted to single-use visualization technology, which became the core of the business.

Pristine Surgical's primary product is the Summit™ 4K single-use surgical arthroscope, which received FDA 510(k) clearance in January 2023 and launched later that year. This sterile, disposable scope is designed for arthroscopic procedures and integrates with existing hospital endoscopy towers, eliminating the need for large capital investments. The device is paired with a cloud-based software platform, Pristine Connect™, which offers HIPAA-compliant video and text capabilities to enhance communication and workflow. The business model operates on a subscription basis, described as "Scopes as a Subscription™", which provides transparent pricing, automated inventory management, and converts fixed capital costs to variable expenses for hospitals and ambulatory surgery centers (ASCs). By eliminating reprocessing and maintenance, the platform aims to reduce costs, improve operating room efficiency, and enhance patient safety.

Headquartered in Manchester, New Hampshire, Pristine Surgical has raised approximately $33-35.7 million in funding through multiple rounds, including a Series D in March 2022. The company is expanding its portfolio to include solutions for laparoscopy and flexible endoscopy.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2013
Headquarters
Manchester, United States
Employees
29
Open positions
None listed
Dealroom signal
27.6/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Surgery, Medical Imaging, Hard Tech, DT and LS, science-based
Technology
Deep Tech

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES DEquity / VC Mar 2022 $15M $60M Ceros capital Markets —
SERIES C✓Equity / VC Mar 2020 $18M $72M Undisclosed —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Pristine Surgical website traffic

Latest recorded traffic for Pristine Surgical is 1.1K monthly website visits, down 15.4% over the last three months. Pristine Surgical's team declined 9.4% over the past year.

Latest monthly visits1.1K 3-month web change-15.4% 1-year team growth-9.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • Ceros capital Markets
Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇺🇸 United States85.7%
🇬🇧 United Kingdom4.8%
🇮🇳 India4.8%
🇵🇭 Philippines4.8%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Pristine Surgical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Pristine Surgical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.